Frontlight ResearchEarly access
Trial site
Kocaeli
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis2 trials
- Myeloproliferative neoplasms2 trials
- Immune thrombocytopenia (ITP)1 trial
- Sjögren's disease1 trial
- Phase
- Phase 34 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals6 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026